Myeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells

por Horinaka, Mano, Yoshida, Tatsushi, Tomosugi, Mitsuhiro, Yasuda, Shusuke, Sowa, Yoshihiro, Sakai, Toshiyuki
Publicado 2014

Discovery of cancer-preventive juices reactivating RB functions

por Masuda, Mitsuharu, Horinaka, Mano, Yasuda, Shusuke, Morita, Mie, Nishimoto, Emi, Ishikawa, Hideki, Mutoh, Michihiro, Sakai, Toshiyuki
Publicado 2023

Novel RAF/MEK inhibitor CH5126766/VS‐6766 has efficacy in combination with eribulin for the treatment of triple‐negative breast cancer

por Ono, Hisako, Horinaka, Mano, Sukeno, Mamiko, Morita, Mie, Yasuda, Shusuke, Nishimoto, Emi, Konishi, Eiichi, Sakai, Toshiyuki
Publicado 2021

The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma

por Isa, Reiko, Horinaka, Mano, Tsukamoto, Taku, Mizuhara, Kentaro, Fujibayashi, Yuto, Taminishi-Katsuragawa, Yoko, Okamoto, Haruya, Yasuda, Shusuke, Kawaji-Kanayama, Yuka, Matsumura-Kimoto, Yayoi, Mizutani, Shinsuke, Shimura, Yuji, Taniwaki, Masafumi, Sakai, Toshiyuki, Kuroda, Junya
Publicado 2022